Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Adverse events data will be reported in Adverse Events section.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient must be scheduled for Contrast enhanced magnetic resonance imaging (CE-MRI) of the liver with Primovist/Eovist based on careful risk/benefit evaluation at the recommended dose in one of the approved indications
Patient must fulfill criteria for moderate (Estimated glomerular filtration rate \[eGFR\] 30 - 59 mL/min/1.73 m\^2) to severe (eGFR \< 30 mL/min/1.73 m\^2) renal impairment.
You may not be if
Gadolinium based contrast agent (GBCA)-enhanced MRI (or administration of a GBCA for any other CE imaging procedure) other than Primovist/Eovist within 12 months prior to administration of Primovist/Eovist
History of existing NSF
Clareo Health | Primovist / Eovist in Renally Impaired Patients
